Healthcare


 Can Market Momentum Transform INmune Bio's Future?

Can Market Momentum Transform INmune Bio's Future?

March 12, 2025 10:19 PM PDT| By Team Kalkine Media

Highlights,Multiple market research firms offer favorable evaluations.,Upward revisions in views have emerged from well‐known institutions.,Institutional participation in the stock has grown steadily.,INmune Bio, Inc. (NASDAQ:INMB) is positioned with...

 Could 2seventy bio Transform Biotechnology?

Could 2seventy bio Transform Biotechnology?

March 12, 2025 10:19 PM PDT| By Team Kalkine Media

Highlights,Mixed market sentiment with diverse viewpoints observed.,Stock exhibited notable price fluctuations and active institutional engagement.,High concentration of institutional holdings and a focus on cell and gene therapy treatments.,2seventy...

 Can Phathom Pharmaceuticals Redefine Biopharma Innovation?

Can Phathom Pharmaceuticals Redefine Biopharma Innovation?

March 12, 2025 10:18 PM PDT| By Team Kalkine Media

Highlights,Mixed professional viewpoints accompany Phathom Pharmaceuticals.,Company officials have adjusted their share positions.,Institutional investment activity remains robust.,In the biopharmaceutical field, companies address unmet medical needs...

 Why Is Danaher Corporation’s Stock Showing Market Fluctuations?

Why Is Danaher Corporation’s Stock Showing Market Fluctuations?

March 12, 2025 09:44 PM PDT| By Team Kalkine Media

Why Is Danaher Corporation’s Stock Showing Market Fluctuations?

 Is CVS Health’s Business Strategy Strengthening Its Growth?

Is CVS Health’s Business Strategy Strengthening Its Growth?

March 12, 2025 09:29 PM PDT| By Team Kalkine Media

Is CVS Health’s Business Strategy Strengthening Its Growth?

 How Does Danaher Maintain Its Leadership In Biotechnology?

How Does Danaher Maintain Its Leadership In Biotechnology?

March 12, 2025 08:36 PM PDT| By Team Kalkine Media

How Does Danaher Maintain Its Leadership in Biotechnology?

 What Do Zoetis’ Financial Metrics Reveal About Stability?

What Do Zoetis’ Financial Metrics Reveal About Stability?

March 12, 2025 07:34 PM PDT| By Team Kalkine Media

What Do Zoetis’ Financial Metrics Reveal About Stability?

 Is This Healthcare Stock Gaining Strength In The Market?

Is This Healthcare Stock Gaining Strength In The Market?

March 12, 2025 07:00 PM PDT| By Team Kalkine Media

Is This Healthcare Stock Gaining Strength In The Market?

 Why Did Victory Capital Management Adjust Its Stake in IQVIA Holdings Inc. (NYSE:IQV)?

Why Did Victory Capital Management Adjust Its Stake in IQVIA Holdings Inc. (NYSE:IQV)?

March 12, 2025 10:27 AM PDT| By Team Kalkine Media

Highlights,Victory Capital Management Inc. reduced its stake in IQVIA Holdings Inc. during the fourth quarter.,Several institutional investors adjusted their holdings in the medical research company.,IQVIA Holdings Inc. operates in the healthcare and...

 Is Supernus Pharmaceuticals (NASDAQ:SUPN) Seeing Increased Institutional Activity?

Is Supernus Pharmaceuticals (NASDAQ:SUPN) Seeing Increased Institutional Activity?

March 12, 2025 09:48 AM PDT| By Team Kalkine Media

Highlights,Smartleaf Asset Management LLC increased its stake in Supernus Pharmaceuticals, reflecting growing institutional activity.,Several financial firms, including Janney Montgomery Scott LLC and Venturi Wealth Management, adjusted their holding...

 Is LeMaitre Vascular Pioneering a New Era in Vascular Health?

Is LeMaitre Vascular Pioneering a New Era in Vascular Health?

March 12, 2025 02:47 AM PDT| By Team Kalkine Media

Highlights,• Significant institutional expansion during the final quarter.,• Robust quarterly earnings accompanied by an increased dividend.,• Steady share performance reflecting a strong market position.,In the realm of vascular healthcare and medic...

 Is Trevi Therapeutics Revolutionizing Chronic Cough Treatment?

Is Trevi Therapeutics Revolutionizing Chronic Cough Treatment?

March 12, 2025 01:22 AM PDT| By Team Kalkine Media

Is Trevi Therapeutics Revolutionizing Chronic Cough Treatment?

 Is Medpace Revolutionizing Clinical Research Services?

Is Medpace Revolutionizing Clinical Research Services?

March 12, 2025 01:19 AM PDT| By Team Kalkine Media

Is Medpace Revolutionizing Clinical Research Services?

 Is Arvinas Shaping the Future of Protein Degradation?

Is Arvinas Shaping the Future of Protein Degradation?

March 12, 2025 01:16 AM PDT| By Team Kalkine Media

Is Arvinas Shaping the Future of Protein Degradation?

 Is Iovance Redefining Cell Therapy?

Is Iovance Redefining Cell Therapy?

March 12, 2025 01:11 AM PDT| By Team Kalkine Media

Is Iovance Redefining Cell Therapy?

 Is This Biopharma Focused on Dermatology Capturing Attention?

Is This Biopharma Focused on Dermatology Capturing Attention?

March 12, 2025 12:29 AM PDT| By Team Kalkine Media

Highlights,Observers have presented various viewpoints about Fortress Biotech’s (NASDAQ:FBIO) direction.,Institutional engagement has expanded, with higher share positions reported in recent quarters.,The enterprise focuses on dermatological and phar...

 Can RNA Therapies Transform Biotech?

Can RNA Therapies Transform Biotech?

March 12, 2025 12:29 AM PDT| By Team Kalkine Media

Highlights:,Varied professional evaluations with notable revisions from multiple financial institutions.,Recent quarterly report recorded a narrower loss compared to expectations amid a revenue downturn.,Significant corporate executive share movement...

 Could LifeMD Ignite a New Era in Telehealth?

Could LifeMD Ignite a New Era in Telehealth?

March 12, 2025 12:28 AM PDT| By Team Kalkine Media

Highlights,LifeMD (NASDAQ:LFMD) expands digital healthcare brands,Recent corporate changes reported among executives,Revenue trends surpass earlier expectations,LifeMD (NASDAQ:LFMD) is part of the telehealth sector, focusing on direct-to-patient serv...

 Seaport Research Partners Provides Commentary on Ayr Wellness First Quarter Earnings

Seaport Research Partners Provides Commentary on Ayr Wellness First Quarter Earnings

March 11, 2025 11:28 PM PDT| By Team Kalkine Media

Highlights,Ayr Wellness is projected to have future earnings challenges, with Q1 2026 showing an expected EPS of ($0.22).,The company's stock recently experienced a significant downturn, with shares decreasing by 17.2%.,Ayr Wellness operates as a mul...

 NeuroMetrix: An Overview of Recent Developments

NeuroMetrix: An Overview of Recent Developments

March 11, 2025 11:28 PM PDT| By Team Kalkine Media

Highlights,Coverage on NeuroMetrix with a specific rating.,Institutional investors, including Renaissance Technologies LLC, acquire stakes in NeuroMetrix.,NeuroMetrix specializes in neurotechnology with products aimed at diagnosing and managing nerve...

Recent Articles






Investing Tips

Previous Next